174 related articles for article (PubMed ID: 26554248)
21. Local hypercoagulative activity precedes hyperfibrinolytic activity in the subdural space during development of chronic subdural haematoma from subdural effusion.
Suzuki M; Kudo A; Kitakami A; Doi M; Kubo N; Kuroda K; Ogawa A
Acta Neurochir (Wien); 1998; 140(3):261-5; discussion 265-6. PubMed ID: 9638263
[TBL] [Abstract][Full Text] [Related]
22. Platelet and other hemostatic characteristics in patients with chronic urticaria.
Isiksacan N; Koser M; Cemsitoglu F; Kucuksezer UC; Gurdol F
Angiology; 2015 Apr; 66(4):387-91. PubMed ID: 25274526
[TBL] [Abstract][Full Text] [Related]
23. Markers of autoreactivity, coagulation and angiogenesis in patients with nonallergic asthma.
Asero R; Tedeschi A; Cugno M
Allergy; 2011 Oct; 66(10):1339-44. PubMed ID: 21658190
[TBL] [Abstract][Full Text] [Related]
24. Activation of coagulation and endothelium with concurrent impairment of anticoagulant mechanisms in patients with typhoid fever.
de Jong HK; Parry CM; van der Vaart TW; Kager LM; van den Ende SJ; Maude RR; Wijedoru L; Ghose A; Hassan MU; Hossain MA; Dondorp AM; Baker S; Faiz MA; Meijers JCM; Wiersinga WJ
J Infect; 2018 Jul; 77(1):60-67. PubMed ID: 29746945
[TBL] [Abstract][Full Text] [Related]
25. Fibrin formation and degradation in patients with arteriosclerotic disease.
Herren T; Stricker H; Haeberli A; Do DD; Straub PW
Circulation; 1994 Dec; 90(6):2679-86. PubMed ID: 7994808
[TBL] [Abstract][Full Text] [Related]
26. Interplay between acute phase response and coagulation/fibrinolysis in chronic spontaneous urticaria.
Grzanka R; Damasiewicz-Bodzek A; Kasperska-Zajac A
Allergy Asthma Clin Immunol; 2018; 14():27. PubMed ID: 30026764
[TBL] [Abstract][Full Text] [Related]
27. Systemic thrombin generation in cancer patients is correlated with extrinsic pathway activation.
Costantini V; De Monte P; Cazzato AO; Stabile AM; Deveglia R; Frezzato E; Paolucci MC
Blood Coagul Fibrinolysis; 1998 Jan; 9(1):79-84. PubMed ID: 9607122
[TBL] [Abstract][Full Text] [Related]
28. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
Kalweit G; Bach J; Huwer H; Winning J; Hellstern P
Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606
[TBL] [Abstract][Full Text] [Related]
29. Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.
MacCallum PK; Cooper JA; Martin J; Howarth DJ; Meade TW; Miller GJ
Thromb Haemost; 2000 Mar; 83(3):421-6. PubMed ID: 10744148
[TBL] [Abstract][Full Text] [Related]
30. Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk.
Cugno M; Tedeschi A; Borghi A; Bucciarelli P; Asero R; Venegoni L; Griffini S; Grovetti E; Berti E; Marzano AV
PLoS One; 2015; 10(6):e0129456. PubMed ID: 26057532
[TBL] [Abstract][Full Text] [Related]
31. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer.
Kohli M; Fink LM; Spencer HJ; Zent CS
Blood Coagul Fibrinolysis; 2002 Jan; 13(1):1-5. PubMed ID: 11994561
[TBL] [Abstract][Full Text] [Related]
32. Parameters associated with chronic spontaneous urticaria duration and severity: a systematic review.
Rabelo-Filardi R; Daltro-Oliveira R; Campos RA
Int Arch Allergy Immunol; 2013; 161(3):197-204. PubMed ID: 23548885
[TBL] [Abstract][Full Text] [Related]
33. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
[TBL] [Abstract][Full Text] [Related]
34. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.
Kalweit GA; Feindt P; Micek M; Gams E; Hellstern P
Thromb Res; 2000 Feb; 97(3):105-11. PubMed ID: 10680641
[TBL] [Abstract][Full Text] [Related]
35. The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome.
Ames PR; Lupoli S; Alves J; Atsumi T; Edwards C; Iannaccone L; Khamashta MA; Hughes GR; Brancaccio V
Br J Rheumatol; 1997 Oct; 36(10):1045-50. PubMed ID: 9374919
[TBL] [Abstract][Full Text] [Related]
36. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.
Kapiotis S; Jilma B; Quehenberger P; Ruzicka K; Handler S; Speiser W
Circulation; 1997 Jul; 96(1):19-21. PubMed ID: 9236409
[TBL] [Abstract][Full Text] [Related]
37. Plasma markers of hypercoagulability in patients with serious infections and risk of septic shock.
Psuja P; Zozulińska M; Turowiecka Z; Cieślikowski W; Vinazzer H; Zawilska K
Clin Appl Thromb Hemost; 2002 Jul; 8(3):225-30. PubMed ID: 12361199
[TBL] [Abstract][Full Text] [Related]
38. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
39. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency.
Cugno M; Zanichelli A; Bellatorre AG; Griffini S; Cicardi M
Allergy; 2009 Feb; 64(2):254-7. PubMed ID: 19076541
[TBL] [Abstract][Full Text] [Related]
40. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
